[Antitumor activity of cisplatin and carboplatin against human tumor xenografts serially transplanted into nude mice--with special reference to gastric carcinomas]. 1987

Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe

Experimental chemotherapy with cisplatin and carboplatin was performed against nine human tumor xenografts serially transplanted into nude mice. Tumors used for the experiment were seven gastric (St-4, St-15, St-40, H-111, SC-2-JCK, SC-6-JCK and Exp-4), one breast (MX-1) and one colon (Co-4) carcinomas. Cisplatin 9 mg/kg and carboplatin 100 mg/kg were administered intraperitoneally (ip). Carboplatin 25 mg/kg was also given ip 4 times every 4 days. The efficacy rates of cisplatin and carboplatin by bolus injection were 77.8% and 66.7% respectively with no statistically significant differences. However, carboplatin was found more effective when given by bolus. The antitumor spectra of both drugs were similar. From these results, these two platinum compounds seemed to be effective against human gastric carcinomas.

UI MeSH Term Description Entries
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009944 Organoplatinum Compounds Organic compounds which contain platinum as an integral part of the molecule. Compounds, Organoplatinum
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft

Related Publications

Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe
January 1998, Anticancer research,
Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe
February 1997, Journal of surgical oncology,
Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe
January 1994, Anticancer research,
Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe
January 1994, Anticancer research,
Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe
November 1988, Nihon Sanka Fujinka Gakkai zasshi,
Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe
August 1990, Japanese journal of cancer research : Gann,
Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe
January 1987, The Japanese journal of surgery,
Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe
July 1984, Nihon Geka Gakkai zasshi,
Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe
January 1992, Anticancer research,
Y Shimoyama, and T Kubota, and S Inoue, and M Kuzuoka, and T Ohishi, and S Oka, and S Kikuyama, and K Ishibiki, and O Abe
September 1989, Japanese journal of clinical oncology,
Copied contents to your clipboard!